Cargando…

Evaluation of Emergency Department Visits by Oncology Patients: A Running Comparison to Admissions and ED Visits Under the CMS OP-35 Ruling

BACKGROUND: Cancer is the second leading cause of death in the United States. The incidence of emergency department (ED) visits by oncology patients has grown over the past years. Some ED visits are medically unnecessary and could be prevented with improved prevention measures. OBJECTIVES: To evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsuhebany, Nada, Brown, Jamie, Echave, Jacquelyne, McBride, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214961/
https://www.ncbi.nlm.nih.gov/pubmed/35755896
http://dx.doi.org/10.6004/jadpro.2022.13.4.2
_version_ 1784731111938588672
author Alsuhebany, Nada
Brown, Jamie
Echave, Jacquelyne
McBride, Ali
author_facet Alsuhebany, Nada
Brown, Jamie
Echave, Jacquelyne
McBride, Ali
author_sort Alsuhebany, Nada
collection PubMed
description BACKGROUND: Cancer is the second leading cause of death in the United States. The incidence of emergency department (ED) visits by oncology patients has grown over the past years. Some ED visits are medically unnecessary and could be prevented with improved prevention measures. OBJECTIVES: To evaluate the incidence and causes of ED visits by cancer patients and evaluate outcomes and disposition of ED visits. METHODS: This single-center, retrospective chart review was conducted in a tertiary medical hospital. We collected data using an electronic medical record and included oncology patients with active cancer who had ED visits from January 1, 2018, to December 31, 2018. Key data collection included baseline demographics; type of malignancy; main chief complaint; clinic visit history; current and past ED visits; treatment and supportive care data; and disposition status if admitted. Pregnant patients, patients without active cancer, and patients who received outpatient care at clinics other than the University of Arizona Cancer Center were excluded. RESULTS: This chart review study screened 1,659 encounters and included 205 encounters. Approximately 70% of the encounters were solid tumor patients and 30% were hematologic malignancies. Nearly 50% of the patients with hematologic malignancies had preventable ED visits while 32.8% of solid tumor patients had preventable ED visits. The most common preventable ED visit reasons in both groups were pain, fever, nausea, vomiting, and dehydration. Almost 50% of the patients in both groups were hospitalized with a median length of stay of 3 days. The majority of admitted patients were discharged home in both the solid tumor (82.3%) and hematologic malignancy (83.8%) groups. CONCLUSION: This study showed that the rate of preventable visits was numerically higher in the hematologic cancer group compared with the solid tumor group. These findings highlight the potential need for implementing prevention measures in the future.
format Online
Article
Text
id pubmed-9214961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-92149612022-06-23 Evaluation of Emergency Department Visits by Oncology Patients: A Running Comparison to Admissions and ED Visits Under the CMS OP-35 Ruling Alsuhebany, Nada Brown, Jamie Echave, Jacquelyne McBride, Ali J Adv Pract Oncol Research & Scholarship BACKGROUND: Cancer is the second leading cause of death in the United States. The incidence of emergency department (ED) visits by oncology patients has grown over the past years. Some ED visits are medically unnecessary and could be prevented with improved prevention measures. OBJECTIVES: To evaluate the incidence and causes of ED visits by cancer patients and evaluate outcomes and disposition of ED visits. METHODS: This single-center, retrospective chart review was conducted in a tertiary medical hospital. We collected data using an electronic medical record and included oncology patients with active cancer who had ED visits from January 1, 2018, to December 31, 2018. Key data collection included baseline demographics; type of malignancy; main chief complaint; clinic visit history; current and past ED visits; treatment and supportive care data; and disposition status if admitted. Pregnant patients, patients without active cancer, and patients who received outpatient care at clinics other than the University of Arizona Cancer Center were excluded. RESULTS: This chart review study screened 1,659 encounters and included 205 encounters. Approximately 70% of the encounters were solid tumor patients and 30% were hematologic malignancies. Nearly 50% of the patients with hematologic malignancies had preventable ED visits while 32.8% of solid tumor patients had preventable ED visits. The most common preventable ED visit reasons in both groups were pain, fever, nausea, vomiting, and dehydration. Almost 50% of the patients in both groups were hospitalized with a median length of stay of 3 days. The majority of admitted patients were discharged home in both the solid tumor (82.3%) and hematologic malignancy (83.8%) groups. CONCLUSION: This study showed that the rate of preventable visits was numerically higher in the hematologic cancer group compared with the solid tumor group. These findings highlight the potential need for implementing prevention measures in the future. Harborside Press LLC 2022-05 2022-06-21 /pmc/articles/PMC9214961/ /pubmed/35755896 http://dx.doi.org/10.6004/jadpro.2022.13.4.2 Text en © 2022 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research & Scholarship
Alsuhebany, Nada
Brown, Jamie
Echave, Jacquelyne
McBride, Ali
Evaluation of Emergency Department Visits by Oncology Patients: A Running Comparison to Admissions and ED Visits Under the CMS OP-35 Ruling
title Evaluation of Emergency Department Visits by Oncology Patients: A Running Comparison to Admissions and ED Visits Under the CMS OP-35 Ruling
title_full Evaluation of Emergency Department Visits by Oncology Patients: A Running Comparison to Admissions and ED Visits Under the CMS OP-35 Ruling
title_fullStr Evaluation of Emergency Department Visits by Oncology Patients: A Running Comparison to Admissions and ED Visits Under the CMS OP-35 Ruling
title_full_unstemmed Evaluation of Emergency Department Visits by Oncology Patients: A Running Comparison to Admissions and ED Visits Under the CMS OP-35 Ruling
title_short Evaluation of Emergency Department Visits by Oncology Patients: A Running Comparison to Admissions and ED Visits Under the CMS OP-35 Ruling
title_sort evaluation of emergency department visits by oncology patients: a running comparison to admissions and ed visits under the cms op-35 ruling
topic Research & Scholarship
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214961/
https://www.ncbi.nlm.nih.gov/pubmed/35755896
http://dx.doi.org/10.6004/jadpro.2022.13.4.2
work_keys_str_mv AT alsuhebanynada evaluationofemergencydepartmentvisitsbyoncologypatientsarunningcomparisontoadmissionsandedvisitsunderthecmsop35ruling
AT brownjamie evaluationofemergencydepartmentvisitsbyoncologypatientsarunningcomparisontoadmissionsandedvisitsunderthecmsop35ruling
AT echavejacquelyne evaluationofemergencydepartmentvisitsbyoncologypatientsarunningcomparisontoadmissionsandedvisitsunderthecmsop35ruling
AT mcbrideali evaluationofemergencydepartmentvisitsbyoncologypatientsarunningcomparisontoadmissionsandedvisitsunderthecmsop35ruling